Hydrafacial Results Presentation Deck
Q1 2023 cost detail
($mm)
Gross
Profit
Selling &
Marketing
23
G&A
R&D
Q1 2023 Q1 2022¹ Δ Q1 2022 Q1 2023
$54.1
38.7
30.4
2.3
$50.9
36.4
26.3
2.2
+$3.2
1. Reflects the impact of immaterial revisions to the financial statements.
+2.3
+4.1
+0.1
62.7%
44.9%
35.2%
2.7%
% net sales
Q1 2022
67.5%
48.3%
34.8%
3.0%
Δ Q1 2022 |Δ Commentary
(4.8%)
(3.4%)
0.4%
(0.2%)
Optimization write-offs and pre-Syndeo launch low
margin refurbished Elite pre-sale impact
Increases in sales commissions associated with
higher revenues partially offset by leverage of fixed
marketing investment; despite upfront investment
for Syndeo international launch
Increase in software expenses, including certain
contract termination costs, and professional
services fees, including patent litigation expenses,
partially offset by lower recruiting related expenses
Relatively flat
BEAUTYHEALTH™View entire presentation